Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2021 Jun 4;77(1):186–196. doi: 10.1111/all.14906

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© 2021 The Authors. Allergy published by European Academy of Allergy and Clinical Immunology and John Wiley & Sons Ltd.

This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made.

PMC Copyright notice

Any treatment arm. ECRS, eosinophilic chronic rhinosinusitis; ITT, intention‐to‐treat; JESREC, Japanese Epidemiological Survey of Refractory Eosinophilic Rhinosinusitis; MedDRA PT, Medical Dictionary for Regulatory Activities Preferred Term; q2w, every 2 weeks; q4w, every 4 weeks; TEAE, treatment‐emergent adverse event. Figure 1 JESREC algorithm. CT, computed tomography; ECRS, eosinophilic chronic rhinosinusitis; JESREC, Japanese Epidemiological Survey of Refractory Eosinophilic Rhinosinusitis; NSAID‐ERD, nonsteroidal antiinflammatory drug‐exacerbated respiratory disease. Figure from: Allergy 75 (2020) 3087–3099 © 2020Asano K, et al. Allergy. Published by John Wiley and Sons Ltd